(Q48253627)

10 February 2018

title

Breakdown of enkephalin and endorphin analogs by brain extracts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A606343

15 July 2022

0 references

0 references

2

Kastin AJ

1 reference

10 February 2018

David H. Coy

3

object named as

Coy DH

1 reference

10 February 2018

author name string

A. Grynbaum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A606343

15 July 2022

N. Marks

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A606343

15 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=606343

15 July 2022

publication date

1 November 1977

1 reference

10 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0361923077900569?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

https://api.elsevier.com/content/article/PII:0361923077900569?httpAccept=text/plain

4 August 2023

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

4 August 2023

published in

Brain Research Bulletin

1 reference

10 February 2018

volume

2

1 reference

10 February 2018

page(s)

479-484

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

The NH2-terminus of C-fragment is resistant to the action of aminopeptidases

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

Specific cleavage of lipotropin C-fragment by endopeptidases; evidence for a preferred conformation

4 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

A superactive antinociceptive pentapeptide, (D-Met2, Pro5)-enkephalinamide

4 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

Synthesis and opioid activities of stereoisomers and other D-amino acid analogs of methionine-enkephalin

4 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

Lipotropin C-Fragment has a cooh-terminal sequence with high intrinsic resistance to the action of exopeptidases

4 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates

4 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

The C-Fragment of β-Lipotropin: An Endogenous Neuroleptic or Antipsychotogen?

4 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog

4 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

Enkephalin and a potent analog facilitate maze performance after intraperitoneal administration in rats

4 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

Biodegradation of α-MSH and derived peptides by rat brain extracts, and by rat and human serum

4 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

On the degradation of enkephalins and endorphins by rat and mouse brain extracts

4 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

The metabolic stability of the enkephalins

4 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

Structure-activity relationships of methionine-enkephalin

4 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

An Analog of Enkephalin Having Prolonged Opiate-Like Effects in Vivo

4 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0361-9230(77)90056-9

4 August 2023

Identifiers

1 reference

10 February 2018

1 reference

10 February 2018